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Background
Aberrant deregulation of some Receptor Tyrosine
Kinases (RTKs) signalling underlies diverse facets of
tumor pathobiology providing an attractive target for
cancer therapy. Searching for novel cancer-associated
RTKs is an important issue to discover new therapeutic
opportunities. For this reason, we investigated the contri-
bution of Receptor tyrosine kinase-like Orphan Receptor
1 (ROR1) to human cancer.
Patients and methods
The level of ROR1 protein expression, phosphorylation
and cellular growth response to RNAi-mediated ROR1
knockdown was evaluated by an integrated screening in a
panel of 43 cancer cell lines. ROR1 auto-kinase activity
and transphosphorylation were determined by biochem-
ical assays. Functional consequences of ROR1 silencing
were evaluated by several in vitro and in vivo biological
assays.
Results
We demonstrated that although ROR1 is expressed in
approximately 75% of the screened cancer cell lines, only
gastric carcinoma cells (HS746T) and non-small cell lung
carcinoma cells (NCI-H1993) exhibit high levels of ROR1
tyrosine phosphorylation and experience growth inhibi-
tion upon ROR1 suppression. Biochemical assays
revealed that ROR1 is a pseudokinase lacking autocataly-
tic activity. Intriguingly, the two phospho-ROR1 positive
cell lines both exhibited amplification and constitutive
activation of the MET oncogene. ROR1 phosphorylation
was abrogated by MET inhibition, indicating MET
dependent transphosphorylation of ROR1. Silencing of
ROR1 in HS746T and NCI-H1993 cells impaired cellular
proliferation, growth and migration in vitro and induced
a dramatic inhibition of tumorigenesis in vivo.
Conclusions
Our data show that ROR1 is a pseudokinase functionally
transphosphorylated by MET RTK, suggesting a critical
role for ROR1 in malignant phenotypes sustained by the
MET oncogene.
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